Misra et al., 2025 - Google Patents
Engineered Nanomaterials in Food and Drugs: From Laboratory to MarketMisra et al., 2025
- Document ID
- 11586163110354876351
- Author
- Misra S
- Wangoo N
- Khare S
- Publication year
External Links
Snippet
This book pans through three major sections of materials and methods used in the engineering of nanomaterials—their applications, ethical issues, and present market share in the field of food and drugs. It presents information on the kind of materials and processes …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making micro-capsules or micro-balloons
- B01J13/02—Making micro-capsules or micro-balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/02—Cosmetic or similar toilet preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Lipid nanoparticles for drug delivery | |
| Andra et al. | A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents | |
| Amoabediny et al. | Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review | |
| Patel et al. | Nanomedicine scale-up technologies: feasibilities and challenges | |
| Duan et al. | A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems | |
| Chavda | Nanobased nano drug delivery: a comprehensive review | |
| Ali et al. | Nanoemulsion: An advanced vehicle for efficient drug delivery | |
| Thassu et al. | Nanoparticulate drug-delivery systems: an overview | |
| Lima-Tenorio et al. | Magnetic nanoparticles: In vivo cancer diagnosis and therapy | |
| Khoee et al. | An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion | |
| Shah et al. | Lipid-based nanocarriers for drug delivery and diagnosis | |
| JP5143231B2 (en) | Copolymer stabilized emulsion | |
| Yin et al. | Nanoparticles | |
| Joseph et al. | Solid lipid nanoparticles for drug delivery | |
| Real et al. | Manufacturing techniques for nanoparticles in drug delivery | |
| Vigneshkumar et al. | Liposomal bionanomaterials for nucleic acid delivery | |
| Shahzad et al. | Drug delivery using nanomaterials | |
| Prajapati et al. | Lipid-Based Drug Delivery Systems: Principles and Applications | |
| Rangan et al. | Trends and methods for nanobased delivery for nutraceuticals | |
| Misra et al. | Engineered Nanomaterials in Food and Drugs: From Laboratory to Market | |
| Manoharan et al. | Various pharmaceutical disperse systems | |
| Vauthier et al. | Processing and scale-up of polymeric nanoparticles | |
| Reddy et al. | Nanoliposomes-A Review: https://doi. org/10.54037/WJPS. 2022.100308 | |
| Hirlekar et al. | Solid lipid nanoparticles and nanostructured lipid carriers: a review | |
| Lankalapalli et al. | Nanoparticulate drug delivery systems: Promising approaches for drug delivery |